• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Oral tazarotene improves quality of life

Article

Washington - A new study shows that oral tazarotene (Tazorac; Allergan Inc., Irvine,Calif.) provides significant improvements in quality of life for sufferers of plaque psoriasis. The same study also illustrates the validity of a new measuring tool, PQOL (Psoriasis Quality of Life)-12, for measuring the disease's severity (see related article on Page 35).

Related Videos
© 2024 MJH Life Sciences

All rights reserved.